ARWR
Arrowhead Pharmaceuticals margins
- Stocks
- Healthcare
- NASDAQ: ARWR
- Margins
Arrowhead Pharmaceuticals shows a gross margin of 100%, an operating margin of -33.8%, an EBITDA margin of -27.1%, and a net margin of -47.8%, although its operating margin is negative at -33.8%, its EBITDA margin is negative at -27.1%, and its net margin is negative at -47.8%. Net margin fell by 21.9 percentage points, while other available margins were stable.
ARWR margin history
Over the last 3 years, Arrowhead Pharmaceuticals's margins averaged 100% gross, -4,210.99% operating, -3,844.55% EBITDA, and -4,257.55% net. For Arrowhead Pharmaceuticals, operating, EBITDA, and net margins are above their three-year averages.
ARWR margin expansion
From the same period last year, operating margin contracted by 15 percentage points, EBITDA margin by 19.8 percentage points, and net margin by 21.9 percentage points, while gross margin was unchanged.
ARWR Gross margin
Over the last 3 years, Arrowhead Pharmaceuticals had an average gross margin of 100%. Against its three-year average, Arrowhead Pharmaceuticals's gross margin is currently 100%, in line with its three-year average. Looking back over the last 3 years, Arrowhead Pharmaceuticals's gross margin reached 100% at its highest point in Jun 2026 and 100% at its lowest in Dec 2023.
ARWR Operating margin
Over the last 3 years, Arrowhead Pharmaceuticals had an average operating margin of -4,210.99%. Against its three-year average, Arrowhead Pharmaceuticals's operating margin is currently -33.8%, 4,177.2 percentage points above its three-year average. Looking back over the last 3 years, Arrowhead Pharmaceuticals's operating margin reached 27.6% at its highest point in Dec 2025 and -25,037.9% at its lowest in Dec 2024.
ARWR EBITDA margin
Reviewing the last 3 years, Arrowhead Pharmaceuticals recorded an average EBITDA margin of -3,844.55%. Arrowhead Pharmaceuticals's current EBITDA margin is -27.1% and is 3,817.5 percentage points above its three-year average. The highest EBITDA margin for Arrowhead Pharmaceuticals was 31.1% in Dec 2025, while the lowest was -22,834.7% in Dec 2024.
ARWR Net margin
Arrowhead Pharmaceuticals's net margin averaged -4,257.55% over the last 3 years. Compared with its three-year average, Arrowhead Pharmaceuticals's current net margin is -47.8% and is 4,209.8 percentage points above its three-year average. Over the last 3 years, Arrowhead Pharmaceuticals's net margin peaked at 18.5% in Dec 2025 and reached a low of -25,588.6% in Dec 2024.
ARWR margin group comparison
With a gross margin of 100%, ARWR stands above the Healthcare sector, the industry and its peers average. Compared to its Healthcare sector average of 68.3%, Arrowhead Pharmaceuticals's gross margin is 46% higher.
ARWR margin peer comparison
Frequently asked questions
What is Arrowhead Pharmaceuticals's gross margin?
The current gross margin for ARWR is 100% as of Jun 30, 2026.
What is Arrowhead Pharmaceuticals's operating margin?
As of Jun 30, 2026, ARWR has an operating margin of -33.8%.
What is Arrowhead Pharmaceuticals's EBITDA margin?
The current EBITDA margin for ARWR is -27.1% as of Jun 30, 2026.
What is Arrowhead Pharmaceuticals's net margin?
The current net margin for ARWR is -47.8% as of Jun 30, 2026.
What are the average margins of ARWR?
Arrowhead Pharmaceuticals's gross, operating, EBITDA, and net margins averaged 100.0% gross, -4,211.0% operating, -3,844.6% EBITDA, and -4,257.6% net over the last 3 years.
What are the highest historical margins of ARWR?
In the last 5 years, the highest margins reported by ARWR were 100% gross in Jun 2026, 27.6% operating in Dec 2025, 31.1% EBITDA in Dec 2025, and 18.5% net in Dec 2025.
What are the lowest historical margins of ARWR?
In the last 5 years, the lowest margins reported by ARWR were 100% gross in Dec 2021, -25,037.9% operating in Dec 2024, -22,834.7% EBITDA in Dec 2024, and -25,588.6% net in Dec 2024.